GPCR
NASDAQ
$49.35
Structure Therapeutics Inc (GPCR)
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $104.59 (+111.94%)
Market Cap
$3.53B
Free Cash Flow Yield
-4.51%
Beta (5Y)
0.83
Price Chart
Valuation
Market Cap$3.53B
P/B2.48
Profitability
EBITDA-$208M
EPS-$2.76
Financial Health
Free Cash Flow Yield-4.51%
Growth & Risk
Beta (5Y)0.83
Sharpe Ratio1.13